Wick Capital Partners, LLC Astrazeneca PLC Transaction History
Wick Capital Partners, LLC
- $316 Million
- Q4 2024
A detailed history of Wick Capital Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Wick Capital Partners, LLC holds 7,972 shares of AZN stock, worth $542,175. This represents 0.17% of its overall portfolio holdings.
Number of Shares
7,972
Previous 18,360
56.58%
Holding current value
$542,175
Previous $1.2 Million
56.57%
% of portfolio
0.17%
Previous 0.19%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,376Shares Held
476MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.1 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.79 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.55 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.63 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.32 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $211B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...